Clinical Advances in

Retinal Diseases

CME Activities

New Data

Clinical Trials in Focus: Durability of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies

Medscape Education, March 2023

Do you know how study designs influence the data with anti-vascular endothelial growth factor (anti-VEGF) therapies? Find out more.
New and Emerging Therapies for Retinal Disease: A Year in Review 

Medscape Education, December 2022

What new data releases and approvals happened in 2022, and what does 2023 hold? The experts discuss, with a focus on neovascular age-related macular degeneration and diabetic macular edema.

New Drugs and Mechanisms of Action

Global Perspectives on Anti-Vascular Endothelial Growth Factor Therapies: If, When, and How to Switch

Medscape Education, March 2023

Do you reload when switching? What intervals do you extend by? How long is feasible between treatments, and how do you monitor? Learn from the experts.
Double Power for Retinal Disease Patients: What Do the New Drugs With Combined Targets Offer?

Medscape Education, November 2022

What are the newest therapeutics for neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME)? How might your patients benefit from these new drugs with novel mechanisms of action? How can they be incorporated into clinical practice? Learn from experts with hands-on experience.
Looking Beyond VEGF: Why Targeting Angiopoietin-2 Can Bring Benefits

Medscape Education, November 2022

Therapies targeting vascular endothelial growth factor (VEGF) have transformed vision for patients with retinal diseases. But can therapeutics targeting additional pathways improve outcomes for our patients?

New Technologies

Retinal Disease: An Update on Emerging Technologies

Medscape Education, August 2023

Do you know what's coming for retinal disease?

0.75 CME
What’s New in Diabetic Eye Disease Technologies

Medscape Education, March 2023

Learn from experts what technologies are in development to treat diabetic retinopathy and diabetic macular edema.
Expert Views: Using Surgical Approaches for Neovascular Age-Related Macular Degeneration in Practice

Medscape Education, December 2022

How do you place an implant in the sclera? Can the suprachoroidal space be used for drug delivery? Learn from surgeons with experience.
Novel Technologies for Treating Neovascular Age-Related Macular Degeneration

Medscape Education, November 2022

Who are good candidates for technologies that extend the durability of anti-vascular endothelial growth factor (VEGF) therapies?

Retinal Disease Updates

Test your Knowledge in Retinal Diseases

Resources

Downloadable Slide Kit

Clinical Advances in Retinal Diseases

Clinical Articles

Steering Committee

Anat Loewenstein, MD, MHA

Steering Committee Chair

Professor of Ophthalmology
Deputy Dean
Tel Aviv University Medical School
Chairman, Department of Ophthalmology
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel

Bio Video

Clare Bailey, MD, FRCOphth

Steering Committee Member

Consultant Ophthalmologist
Director of the Retinal Research and Treatment Unit
Bristol Eye Hospital
Bristol, United Kingdom

Bio Video

Gemmy Cheung, MD

Steering Committee Member

Professor of Ophthalmology
Duke-NUS Medical School
National University of Singapore
Senior Consultant Ophthalmologist
Singapore National Eye Center
Singapore, Republic of Singapore

Bio Video

Nicole Eter, MD, PhD

Steering Committee Member

Professor and Chair
Department of Ophthalmology
University of Muenster Medical Center
Muenster, Germany

Bio Video

Carl D. Regillo, MD

Steering Committee Member

Professor of Ophthalmology
Thomas Jefferson University School of Medicine
Director, Wills Eye Hospital Retina Service
Philadelphia, Pennsylvania, United States

Bio Video

Patricio Schlottmann, MD

Steering Committee Member

Professor
University of Buenos Aires
Ophthalmology Director
Medical Research Organization
Buenos Aires, Argentina

Bio Video

Steering Committee

Anat Loewenstein, MD, MHA

Steering Committee Chair

Has the following relevant financial relationships:

Consultant or advisor for: AbbVie; Bayer; Beyeonics; Notal Vision; Novartis; Roche

Clare Bailey, MD, FRCOphth

Steering Committee Member

Has the following relevant financial relationships:

Consultant or advisor for: Alimera Sciences; Appelis; Bayer; Boehringer Ingelheim; Janssen; Novartis; Roche

Speaker or member of speakers bureau for: Bayer; Roche

Research funding from: Bayer; Gyroscope; Roche

Gemmy Cheung, MD

Steering Committee Member

Has the following relevant financial relationships:

Consultant or advisor for: AbbVie; Avirmax; Bayer; Boehringer Ingelheim; Janssen; Novartis; Roche; Topcon; Zeiss

Speaker or member of speakers bureau for: AbbVie; Bayer; Novartis; Roche; Zeiss

Research funding from: Bayer; Boehringer Ingelheim; Novartis; Retimark; Roche; Topcon; Zeiss

Stock options from: Avirmax

Nicole Eter, MD, PhD

Steering Committee Member

Has the following relevant financial relationships:

Consultant or advisor for: Alcon; Allergan; Apellis; Bayer; Genentech; Novartis; Roche

Speaker or member of speakers bureau for: Alcon; Allergan; Apellis; Bayer; Genentech; Novartis; Roche

Research funding from: Allergan; Apellis; Bayer; Novartis

Carl D. Regillo, MD

Steering Committee Member

Has the following relevant financial relationships:

Consultant or advisor for: 4DMT; Adverum; Aldeyra; Annexon; Apellis; Aviceda; Bausch and Lomb; Clearside; EyePoint; Genentech; Graybug; Iveric Bio; Kodiak; Lineage; NGM; Notal; Novartis; Ocugen; Regenxbio; Stealth BioTherapeutics; Thea

Research funding from: Adverum; Annexon; Apellis; EyePoint; Genentech; Gyroscope; Iveric Bio; Kodiak; NGM; Novartis; Ocugen; Regeneron; Regenxbio

Contracted researcher for: Adverum; Annexon; Apellis; EyePoint; Genentech; Gyroscope; Iveric Bio; Kodiak; NGM; Novartis; Ocugen; Regeneron; Regenxbio

Stock options from: Iveric Bio; Ocugen

Patricio Schlottmann, MD

Steering Committee Member

Has the following relevant financial relationships:

Consultant or advisor for: Novartis; Roche

Speaker or member of speakers bureau for: Allergan; Novartis; Roche

Contracted researcher for: Apellis; Bayer; Iveric Bio; Novartis; Opthea; Roche